Efficacy of infliximab and adalimumab therapy in very early onset, severe ulcerative colitis
{{output}}
Aim: This multicenter study is the first one on Iranian children with very early onset ulcerative colitis (UC) and one of the few studies about the effect of biological therapy in children with UC under 7 years of age. ... ...
